Question 1

What is Fulvestrant?

Accepted Answer

Fulvestrant is a cancer medication that belongs to a class of drugs known as estrogen receptor antagonists. It works by binding to and blocking estrogen receptors, which helps to slow or stop the growth of cells that rely on this hormone to multiply.

By reducing the number of available estrogen receptors in the body, the medication interferes with the hormonal signals that certain tumors use to develop. This process limits the ability of hormone-dependent cells to grow and spread.

Question 2

What is Fulvestrant used for?

Accepted Answer

Fulvestrant is used to treat hormone receptor-positive advanced breast cancer .

Question 3

How does Fulvestrant work?

Accepted Answer

Mechanism of Action

Many breast cancers are hormone receptor-positive, which means they rely on the hormone estrogen to grow and multiply. Fulvestrant belongs to a class of medications known as estrogen receptor antagonists or selective estrogen receptor degraders (SERDs).

This medication works through two primary actions:

Blocking receptors: Fulvestrant binds to the estrogen receptors on cancer cells. This prevents naturally occurring estrogen from attaching to those cells and sending signals for the cancer to grow.

Reducing receptor count: Unlike some other hormone therapies that only block the receptor, fulvestrant also causes the estrogen receptors to be broken down and destroyed. This reduces the overall number of receptors available on the cancer cells.

By interfering with the way cancer cells use estrogen, fulvestrant helps to slow the progression of the disease or shrink existing tumors.

Question 4

What are the brand names for Fulvestrant?

Accepted Answer

Fulvestrant is sold under the brand name Faslodex .

Question 5

What are the active ingredients in Fulvestrant?

Accepted Answer

The active ingredient in Fulvestrant is fulvestrant .

Question 6

What are the side effects of Fulvestrant?

Accepted Answer

Common side effects of Fulvestrant may include:

injection site pain

hot flashes

nausea

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Fulvestrant?

Accepted Answer

Fulvestrant belongs to the estrogen receptor antagonist drug class.

Question 8

What is the dosage of Fulvestrant and how do I take it?

Accepted Answer

How Fulvestrant is Administered

Fulvestrant is given as an injection into the muscle of the buttocks (intramuscularly). Because of the specific technique required, it must be administered by a healthcare professional in a medical setting, such as a doctor's office or clinic.

A full dose usually consists of two separate injections, with one administered into each buttock. The injections are typically given slowly.

General Dosing Schedule

The treatment schedule for fulvestrant generally follows a specific pattern:

Initial Phase: You will likely receive the first few doses two weeks apart.

Maintenance Phase: After the initial doses, the medication is usually administered once every month.

Your healthcare provider may prescribe fulvestrant alone or in combination with other oral medications, depending on your specific condition and treatment history.

Missed Doses

It is important to receive every scheduled injection. If you miss an appointment for your fulvestrant dose, contact your healthcare provider immediately to reschedule. Keeping a consistent schedule helps ensure the medication works effectively.

Question 9

Is Fulvestrant safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Fulvestrant may cause harm to an unborn baby if used during pregnancy. Healthcare providers typically perform a pregnancy test to confirm a patient is not pregnant before starting treatment with this medication. If a patient becomes pregnant while receiving this drug, they should notify their healthcare provider immediately.

Contraception Requirements

Because of the potential risks to a fetus, effective birth control is required during and after treatment:

For females: Use effective contraception during treatment and for one year after the final dose of fulvestrant.

For males: Men with female partners of reproductive potential should use effective contraception during treatment and for one year after the final dose.

Breastfeeding

It is not known whether fulvestrant passes into human breast milk. Due to the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment and for one year after the last dose. Patients should discuss the best way to feed their baby during this time with their healthcare team.

Question 10

What forms and strengths does Fulvestrant come in?

Accepted Answer

Fulvestrant is provided in the following form:

Intramuscular Injection: A viscous solution intended for injection into the muscle.

This medication is typically supplied in prefilled syringes and must be administered by a doctor or nurse in a clinical setting, such as a medical office or hospital.

Question 11

What is the FDA approval status of Fulvestrant?

Accepted Answer

FDA Approval Status

Fulvestrant was first approved by the U.S. Food and Drug Administration (FDA) in 2002. It is classified as an estrogen receptor antagonist. Since its initial approval, the FDA has expanded its indications to include use as a first-line treatment and in combination with several targeted therapies for advanced breast cancer.

Approved Indications

Fulvestrant is FDA-approved for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in the following scenarios:

As a single agent for postmenopausal women who have not previously received endocrine therapy.

As a single agent for postmenopausal women whose disease has progressed following other antiestrogen therapy.

In combination with CDK4/6 inhibitors (such as palbociclib, abemaciclib, or ribociclib) for postmenopausal women or for women whose disease has progressed after endocrine therapy.

Recent Regulatory Actions

The FDA has recently approved new combination regimens involving fulvestrant for specific genetic profiles:

In November 2023, the FDA approved the use of fulvestrant with capivasertib for adults with HR-positive, HER2-negative advanced or metastatic breast cancer with PIK3CA, AKT1, or PTEN alterations.

In October 2024, the FDA approved fulvestrant in combination with inavolisib and palbociclib for adults with PIK3CA-mutated, HR-positive, HER2-negative advanced or metastatic breast cancer.

Safety Communications

There are no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) currently required by the FDA for fulvestrant. It is administered as an intramuscular injection by a healthcare professional.

Question 12

What should I know about Fulvestrant and cost?

Accepted Answer

Factors Influencing Cost

Fulvestrant is an intramuscular injection administered by a healthcare professional in a medical office or clinic. The total cost of treatment often depends on several factors beyond the price of the drug itself.

Administration Fees: Because this medication is given by a professional, costs may include facility fees and charges for the injection procedure.

Generic vs. Brand Name: Generic fulvestrant is available and typically costs less than the brand-name version, Faslodex.

Insurance Coverage: Most insurance plans cover fulvestrant, but out-of-pocket costs like deductibles and coinsurance vary by plan.

Financial Assistance: Some patients may be eligible for manufacturer-sponsored patient assistance programs or copay cards to help reduce costs.

To understand the specific costs for your situation, it is best to contact your insurance provider or the billing department of the facility where you receive treatment.

Fulvestrant

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?